Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.
The Food and Drug Administration granted accelerated approval to Lynparza (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes, as detected by an FDA-approved test.
Shoppers Drug Mart is looking to raise $750,000 in support of Look Good Feel Better across its stores in the Aberta, Atlantic and Prairies regions. And in Ontario, the Canadian drug store retailer is hoping to raise $375,000 for the Canadian Breast Cancer Foundation.
Ethnic hair care brand Creme of Nature is continuing its partnership with Look Good Feel Better, a national public service program created to help individuals with cancer to look good, improve their self-esteem and thereby manage their treatment and recovery with greater confidence.
As part of its new Women’s Wellness initiative, Schnucks Pharmacies has announced that four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) will be available for $9 with a valid prescription.
Recurrence of hormone-related breast cancer was cut by half in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs, according to data published last week in Cancer Research, a journal of the American Association for Cancer Research.
In honor of Breast Cancer Awareness Month, Psi Bands on Monday formed a charitable partnership with the National Breast Cancer Foundation, which provides help to those affected by breast cancer through early detection, education and support services.
Roche on Wednesday announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, a privately held biotechnology company based in San Diego.
New approaches to treating cancer are creating big growth opportunities for the pharmaceutical industry, Moody's Investors Service stated in a report released Thursday titled "Cancer Breakthroughs Bring New Options for Patients and Revenue Streams to Big Pharma."
Pfizer announced plans to submit a new drug application with the Food and Drug Administration for palbociclib, which is used for the first-line systemic treatment of post-menopausal women with advanced or metastatic breast cancer.
The pace of annual global spending on oncology medicines — which is approaching the $100 billion threshold — has moderated over the past five years, even as a surge in innovative and targeted therapies has brought new therapeutic options to the growing number of patients being treated for cancer and as survival rates for most tumor types continue to increase, according to a new report released Tuesday by the IMS Institute for Healthcare Informatics.
A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells, according to research published this month in the International Journal of Oncology.